The Role of BCL2 Family of Apoptosis Regulator Proteins in Acute and Chronic Leukemias
Flora Tzifi,Christina Economopoulou,Dimitrios Gourgiotis,Alexandros Ardavanis,Sotirios G. Papageorgiou,Andreas Scorilas +5 more
Reads0
Chats0
TLDR
Current knowledge on the role of BCL2 apoptosis regulator proteins in acute and chronic leukemias is described to lead to the design of new therapies which may improve patients' survival.Abstract:
The disturbance of apoptosis molecular signaling pathways is involved in carcinogenesis. BCL2 family of proteins is the hallmark of apoptosis regulation. In the last decade, new members of BCL2 gene family were discovered and cloned and were found to be differentially expressed in many types of cancer. BCL2 protein family, through its role in regulation of apoptotic pathways, is possibly related to cancer pathophysiology and resistance to conventional chemotherapy. It is well known that leukemias are haematopoietic malignancies characterized by biological diversity, varied cytogenetics, different immunophenotype profiles, and diverse outcome. Current research focuses on the prognostic impact and specific role of these proteins in the pathogenesis of leukemias. The understanding of the molecular pathways that participate in the biology of leukemias may lead to the design of new therapies which may improve patients' survival. In the present paper, we describe current knowledge on the role of BCL2 apoptosis regulator proteins in acute and chronic leukemias.read more
Citations
More filters
Journal ArticleDOI
Targeting Mitochondrial Structure Sensitizes Acute Myeloid Leukemia to Venetoclax Treatment
Xufeng Chen,Christina Glytsou,Hua Zhou,Sonali Narang,Denis E. Reyna,Andrea Lopez,Theodore Sakellaropoulos,Yixiao Gong,Yixiao Gong,Andreas Kloetgen,Yoon Sing Yap,Eric Wang,Evripidis Gavathiotis,Aristotelis Tsirigos,Raoul Tibes,Iannis Aifantis +15 more
TL;DR: Using a genome-wide CRISPR/Cas9 screen in human AML, genes involved in mitochondrial biological processes participate in the acquisition of venetoclax resistance are revealed, suggesting that targeting mitochondrial architecture may provide a promising approach to circumvent venetclax resistance.
Journal ArticleDOI
Molecular vehicles for mitochondrial chemical biology and drug delivery.
TL;DR: The features of existing delivery vectors developed for targeting probes and therapeutics to this highly impermeable organelle are summarized and the major applications of mitochondrial targeting of bioactive molecules are discussed, which include the detection and treatment of oxidative damage, combating bacterial infections, and the development of new therapeutic approaches for cancer.
Journal ArticleDOI
Cancer chemoresistance; biochemical and molecular aspects: a brief overview
Saeed Kachalaki,Mina Ebrahimi,Leila Mohamed Khosroshahi,Sina Mohammadinejad,Behzad Baradaran +4 more
TL;DR: Molecular mechanisms and tumor microenvironment leading to decreased drug sensitivity, and strategies of reversing drug resistance are described.
Journal ArticleDOI
Chronic myeloid leukemia stem cells
Mohammad Houshmand,Giorgia Simonetti,Paola Circosta,Valentina Gaidano,Alessandro Cignetti,Giovanni Martinelli,Giuseppe Saglio,Robert Peter Gale +7 more
TL;DR: Whether CML LSCs are susceptible to targeting by tyrosine kinase inhibitors (TKIs) and other drugs, and whether elimination of CMLLSCs is needed to achieve therapy-free remission or cure CML is considered.
Journal ArticleDOI
Synthesis of Zinc oxide nanoparticles from Marsdenia tenacissima inhibits the cell proliferation and induces apoptosis in laryngeal cancer cells (Hep-2).
Yu Wang,Yayuan Zhang,Yan Guo,Jianguang Lu,Vishnu Priya Veeraraghavan,Surapaneni Krishna Mohan,Chao Wang,Xiaoguang Yu +7 more
TL;DR: Biosynthesis of Zinc oxide nanoparticles from natural plants stands as a promising nanodrug delivery system in cancer therapeutics and its anti cancer potency was assessed against in vitro laryngeal cancer cell line Hep-2, suggesting that biosynthesized M.t-ZnONPs, a valid anticancer strategy in treating various cancer, is an effective anticancer agent.
References
More filters
Journal ArticleDOI
Mitochondria and apoptosis
Douglas R. Green,John C. Reed +1 more
TL;DR: A variety of key events in apoptosis focus on mitochondria, including the release of caspase activators (such as cytochrome c), changes in electron transport, loss of mitochondrial transmembrane potential, altered cellular oxidation-reduction, and participation of pro- and antiapoptotic Bcl-2 family proteins.
Journal ArticleDOI
The Bcl-2 Protein Family: Arbiters of Cell Survival
Jerry M. Adams,Suzanne Cory +1 more
TL;DR: Bcl-2 and related cytoplasmic proteins are key regulators of apoptosis, the cell suicide program critical for development, tissue homeostasis, and protection against pathogens.
Journal ArticleDOI
The BCL-2 protein family: opposing activities that mediate cell death
TL;DR: New insights into interactions among BCL-2 family proteins reveal how these proteins are regulated, but a unifying hypothesis for the mechanisms they use to activate caspases remains elusive.
Journal ArticleDOI
STATs and Gene Regulation
TL;DR: The discovery of a STAT in Drosophila, and most recently in Dictyostelium discoideum, implies an ancient evolutionary origin for this dual-function set of proteins.
Journal ArticleDOI
The Bcl2 family: regulators of the cellular life-or-death switch.
Suzanne Cory,Jerry M. Adams +1 more
TL;DR: A better understanding of how the Bcl2 family controls caspase activation should result in new, more effective therapeutic approaches in tissue homeostasis and cancer.
Related Papers (5)
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Tilman Oltersdorf,Steven W. Elmore,Alexander R. Shoemaker,Robert C. Armstrong,David J. Augeri,Barbara A. Belli,Milan Bruncko,Thomas L. Deckwerth,Jürgen Dinges,Philip J. Hajduk,Mary K. Joseph,Shinichi Kitada,Stanley J. Korsmeyer,Stanley J. Korsmeyer,Kunzer Aaron R,Anthony Letai,Chi Li,Michael J. Mitten,David G. Nettesheim,Shi Chung Ng,Paul Nimmer,Jacqueline M. O'Connor,Anatol Oleksijew,Andrew M. Petros,John C. Reed,Wang Shen,Stephen K. Tahir,Craig B. Thompson,Kevin J. Tomaselli,Baole Wang,Wendt Michael D,Haichao Zhang,Stephen W. Fesik,Saul H. Rosenberg +33 more